Cargando…

Deoxysphingolipids as candidate biomarkers for a novel SPTLC1 mutation associated with HSAN-I

Detalles Bibliográficos
Autores principales:	Boso, Federica, Armirotti, Andrea, Taioli, Federica, Ferrarini, Moreno, Nobbio, Lucilla, Cavallaro, Tiziana, Fabrizi, Gian Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer 2019
Materias:	Clinical/Scientific Notes
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6807659/ https://www.ncbi.nlm.nih.gov/pubmed/31742231 http://dx.doi.org/10.1212/NXG.0000000000000365

Ejemplares similares

Aberrant Splicing in GJB1 and the Relevance of 5′ UTR in CMTX1 Pathogenesis
por: Boso, Federica, et al.
Publicado: (2020)

Specific Deoxyceramide Species Correlate with Expression of Macular Telangiectasia Type 2 (MacTel2) in a SPTLC2 Carrier HSAN1 Family
por: Wilson, Lindsey M. Q., et al.
Publicado: (2023)

Mutation screening of SPTLC1 and SPTLC2 in amyotrophic lateral sclerosis
por: Li, Chunyu, et al.
Publicado: (2023)

The SPTLC1 p.S331 mutation bridges sensory neuropathy and motor neuron disease and has implications for treatment
por: Fiorillo, Chiara, et al.
Publicado: (2022)

Plasma 1-deoxysphingolipids are predictive biomarkers for type 2 diabetes mellitus
por: Othman, Alaa, et al.
Publicado: (2015)

Rare among Rare: Phenotypes of Uncommon CMT Genotypes
por: Gentile, Luca, et al.
Publicado: (2021)

Deoxysphingolipids: β-Cell, Beware of These New Kids on the Block
por: Kowluru, Anjaneyulu
Publicado: (2014)

Modulating serine palmitoyltransferase‐deoxysphingolipid axis in cancer therapy
por: Xiang, Yuancai, et al.
Publicado: (2020)

RFC1 AAGGG repeat expansion masquerading as Chronic Idiopathic Axonal Polyneuropathy
por: Tagliapietra, Matteo, et al.
Publicado: (2021)

New Insights into the Neuromyogenic Spectrum of a Gain of Function Mutation in SPTLC1
por: Kölbel, Heike, et al.
Publicado: (2022)

HSAN-VI: A spectrum disorder based on dystonin isoform expression
por: Lynch-Godrei, Anisha, et al.
Publicado: (2020)

Deoxysphingolipids and ether-linked diacylglycerols accumulate in the tissues of aged mice
por: Ando, Ayumi, et al.
Publicado: (2019)

A third HSAN5 mutation disrupts the nerve growth factor furin cleavage site
por: Shaikh, Samiha S, et al.
Publicado: (2018)

Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis
por: Johnson, Janel O., et al.
Publicado: (2021)

A novel NGF mutation clarifies the molecular mechanism and extends the phenotypic spectrum of the HSAN5 neuropathy
por: Carvalho, Ofélia P, et al.
Publicado: (2010)

Clinical feature difference between juvenile amyotrophic lateral sclerosis with SPTLC1 and FUS mutations
por: Wang, Peishan, et al.
Publicado: (2023)

Plasma 1-deoxysphingolipids are early predictors of incident type 2 diabetes mellitus
por: Mwinyi, J., et al.
Publicado: (2017)

Imbalanced unfolded protein response signaling contributes to 1-deoxysphingolipid retinal toxicity
por: Rosarda, Jessica D., et al.
Publicado: (2023)

Metabolism of HSAN1- and T2DM-associated 1-deoxy-sphingolipids inhibits the migration of fibroblasts
por: Karsai, Gergely, et al.
Publicado: (2021)

1-Deoxysphingolipids Encountered Exogenously and Made de Novo: Dangerous Mysteries inside an Enigma
por: Duan, Jingjing, et al.
Publicado: (2015)

Correction: Plasma 1-deoxysphingolipids are early predictors of incident type 2 diabetes mellitus
por: Mwinyi, J., et al.
Publicado: (2017)

Cytotoxicity of 1-deoxysphingolipid unraveled by genome-wide genetic screens and lipidomics in Saccharomyces cerevisiae
por: Haribowo, A. Galih, et al.
Publicado: (2019)

1-Deoxysphingolipids, Early Predictors of Type 2 Diabetes, Compromise the Functionality of Skeletal Myoblasts
por: Tran, Duyen, et al.
Publicado: (2021)

Novel HSAN1 Mutation in Serine Palmitoyltransferase Resides at a Putative Phosphorylation Site That Is Involved in Regulating Substrate Specificity
por: Ernst, Daniela, et al.
Publicado: (2015)

Mutations at Ser331 in the HSN type I gene SPTLC1 are associated with a distinct syndromic phenotype
por: Auer-Grumbach, Michaela, et al.
Publicado: (2013)

1-Deoxysphingolipid synthesis compromises anchorage-independent growth and plasma membrane endocytosis in cancer cells
por: Cordes, Thekla, et al.
Publicado: (2022)

Sphingomyelin as a myelin biomarker in CSF of acquired demyelinating neuropathies
por: Capodivento, Giovanna, et al.
Publicado: (2017)

Oral manifestations and prosthetic rehabilitation in hereditary sensory and autonomic neuropathy (HSAN)type IV: a case report
por: Ofluoglu, Duygu, et al.
Publicado: (2016)

Late-onset leukoencephalopathy in a patient with recessive EARS2 mutations
por: Monfrini, Edoardo, et al.
Publicado: (2020)

Metabolic Syndrome, Neurotoxic 1-Deoxysphingolipids and Nervous Tissue Inflammation in Chronic Idiopathic Axonal Polyneuropathy (CIAP)
por: Hube, Larissa, et al.
Publicado: (2017)

SERIneALanine Killer: SPT promiscuity inhibits tumour growth via intra-tumoral deoxysphingolipid production
por: Falcone, Mattia, et al.
Publicado: (2020)

A Comprehensive Functional Analysis of NTRK1 Missense Mutations Causing Hereditary Sensory and Autonomic Neuropathy Type IV (HSAN IV)
por: Shaikh, Samiha S., et al.
Publicado: (2016)

Human TrkA(R649W) mutation impairs nociception, sweating and cognitive abilities: a mouse model of HSAN IV
por: Pacifico, Paola, et al.
Publicado: (2022)

Association of the SPTLC3 rs364585 polymorphism and serum lipid profiles in two Chinese ethnic groups
por: Zhang, Qing-Hui, et al.
Publicado: (2017)

Upregulation of the serine palmitoyltransferase subunit SPTLC2 by endoplasmic reticulum stress inhibits the hepatic insulin response
por: Kim, Goon-Tae, et al.
Publicado: (2022)

Murine endothelial serine palmitoyltransferase 1 (SPTLC1) is required for vascular development and systemic sphingolipid homeostasis
por: Kuo, Andrew, et al.
Publicado: (2022)

Exploiting Sphingo- and Glycerophospholipid Impairment to Select Effective Drugs and Biomarkers for CMT1A
por: Visigalli, Davide, et al.
Publicado: (2020)

Hepatic Expression of the Serine Palmitoyltransferase Subunit Sptlc2 Reduces Lipid Droplets in the Liver by Activating VLDL Secretion
por: Kim, Goon-Tae, et al.
Publicado: (2020)

Comprehensive Computational Analysis of Protein Phenotype Changes Due to Plausible Deleterious Variants of Human SPTLC1 Gene
por: Sadaf, Tayyaba, et al.
Publicado: (2019)

SPTLC1 variants associated with ALS produce distinct sphingolipid signatures through impaired interaction with ORMDL proteins
por: Lone, Museer A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ls0bqqpg58kifh1svk29ao0892